Leksell Gamma Knife® Icon™
A new era in intracranial radiosurgery
Building on Leksell Gamma Knife® precision and adding new technology, Leksell Gamma Knife® Icon™ gives clinicians the option to perform single or fractionated frame-based or frameless treatments, allowing for more individualized delivery—without sacrificing precision and accuracy. Addressing the growing radiosurgery market, Icon makes Leksell Gamma Knife radiosurgery more flexible and easier to use, allowing more clinics to build an intracranial radiosurgery program.
What’s new?
- Choice of workflows and types of fixation with Leksell Gamma Knife Icon
Watch the video - Leksell Gamma Knife Software 2020
Learn more - Remote treatment planning boosts productivity and collaboration
Read the article - A World-Class Stereotactic Center of Excellence at Princess Alexandra Hospital
Learn more
Unique Features
- Fully integrated, non-complex system design
- Automatic delivery correction and dose evaluation
- 2-4 times lower dose to healthy brain
Essential Features
- Quick QA procedure (maximum 10 minute daily)
- Fast and intuitive dose planning
- Icon users average >500 intracranial radiosurgery cases/year
Clinical confidence
Consistently accurate and precise treatment delivery
“The ability to fractionate treatments has allowed us to expand the case mix, for example to patients with tumors that are situated close to critical structures, allowing such patients to benefit from the superior dosimetry of Leksell Gamma Knife.”
No need for margins
Planned dose equals delivered dose with guaranteed system accuracy over lifetime of device1
Lower dose to healthy tissue
2-4 times lower dose to healthy brain and lowest dose to rest of body compared to other SRS modalities2
Evidence-based performance
Clinically proven, extensively published and expertly supported technology
1 With a Platinum service contract
2 Ma L, Nichol A, Hossain S, et al. (2014) “Variable dose interplay effects across radiosurgical apparatus in treating multiple brain metastases”. Int J CARS. Published online: 20 April 2014. doi:10.1007/s11548-014-1001-4
Outstanding performance
Designed to ensure maximum availability
“We need Icon to cover all of the patients requiring Gamma Knife treatment. With Icon, we can expand the treatment volumes with Gamma Knife and treat 10 to 20 percent more patients.”
Guaranteed >98% uptime
Fully integrated system design – with no moving parts during delivery – ensures minimal downtime
Flexible and intuitive workflows
Well-defined workflows enable fast and intuitive dose planning, even for complex cases
Operational efficiency
Fully automated treatment delivery allows for small teams and high throughput regardless of treatment volume
Stand out with the best
The clear choice for intracranial radiosurgery
“We invested in Icon for its flexibility and for the ability to extend the advantages of Gamma Knife’s dose conformality and drop off to a wider range of patients—including those with larger lesions or lesions abutting sensitive organs.”
System without compromise
Icon is specifically designed for intracranial radiosurgery and has unique dosimetrical capabilities
Individual treatment
Equally high accuracy and ease of use for frame-based or frameless treatments, and for single or multiple targets
Future-safe technology
Well-defined upgrade paths and proactive support through Elekta Care service
See the evidence
Choice of workflows and types of fixation with Leksell Gamma Knife Icon
Enabling collaboration with referring hospitals
Chose between frameless and frame-based immpbilization
Effective and faster treatment of brain metastases
Linac and LGK Icon combination treatment
Sharp dose fall off with no compromise
Treating AVMs (arteriovenous malformations) and Trigeminal Neuralgia with Leksell Gamma Knife Icon
Dosimetric advantage of LGK Icon for lesions close to critical brain structures
Treating brain metastasis within the brain stem
Collaborative planning on Leksell GammaPlan
A calming and stress-free patient experience
Unparalleled dose distribution with Leksell Gamma Knife Icon
Benefits of a dedicated intracranial treatment system
A better choice to treat multiple brain metastasis
Expanded clinical scope and hypofractionation